Monday, July 3, 2017

Closing Of The Deal With Hoth Therapeutics - Spherix Inc


Spherix Inc. Announces Closing of the Deal with Hoth Therapeutics.Hoth Therapeutics is a development stage biopharmaceutical company focused on the development of therapeutics for patients suffering from atopic dermatitis, such as eczema.

Info:
www.prnewswire.com/news-releases/spherix-inc-announces-closing-of-the-deal-with-hoth-therapeutics-300482908.html

No comments:

Post a Comment